You are here

RX-3117

Key FDA Decisions and Trial Results Expected in October

24/7 Wall St

Tue, 10/4/16 - 10:07 am

clinical trials

Celldex Therapeutics

Cerulean Pharma

Anthera Pharmaceuticals

Rexahn's Human Data Confirms Anti-Cancer Advantage

Yahoo

Wed, 09/30/15 - 09:41 am

Rexahn's Lead Drug RX-3117 Beats Lilly's Gemzar In One-To-One Face Off

Seeking Alpha

Tue, 01/13/15 - 04:28 pm

Why Rexahn Pharmaceuticals (RNN) Is Up Today

TheStreet.com

Fri, 01/10/14 - 10:56 am

Rexahn's Recent Clinical Data Points To A New And Better Chemotherapy Pill

Seeking Alpha

Mon, 10/7/13 - 08:48 am

Bristol-Myers Squibb

Rexahn Regains Rights To Novel Cancer Drug As Teva Continues Its Pipeline Stumble

Seeking Alpha

Fri, 09/6/13 - 10:31 am

Teva-Rexahn Deal Terminated - Analyst Blog

NASDAQ

Sat, 08/31/13 - 11:59 am

Rexahn says to continue RX-3117 development with Teva

The Fly on the Wall

Tue, 02/19/13 - 10:07 am

Rexahn Pharmaceuticals: Update On Cancer Drugs

Seeking Alpha

Fri, 05/18/12 - 11:00 am

Teva Pharmaceuticals

akt protein inhibitor